HDFC Securities expects Aurobindo Pharma to touch Rs 760 News News / News 6 years ago 518 Views comments Aurobindo Pharma gains ahead of US Food and Drug Administration (US FDA) target action date for Renvela generic. In an interview to CNBC-TV18, Amey Ch... Read more
News Buy Edelweiss, JSPL, Sundram Fasteners, Hindalco, Havells India: Ashwani Gujral News / News - 6 years ago
News Market Update: CNX Energy outperforms as RIL hits record high, HDFC Bank hits 52-week high News / News - 6 years ago
News China#39;s advanced #39;hypersonic#39; missile threat to India, US, Japan: Report News / News - 6 years ago
News Gurmeet Ram Rahim rape verdict: At least 30 dead, 250 hurt in mob violence News / News - 6 years ago
News 56 lakh new taxpayers added, no inconsistency in government data: CBDT News / News - 6 years ago
Comments